Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin sensitivity describes how well your body’s cells respond to the hormone’s signal—a central determinant in healthy metabolism. It is not a molecule itself but rather a physiological property reflecting molecular interactions at the cellular level involving key signaling pathways downstream from the activated INSR receptor complex.
Varies depending on the drug. Metformin reduces hepatic glucose production and increases insulin sensitivity. TZDs activate PPARγ, increasing insulin sensitivity. Sulfonylureas stimulate insulin secretion. Insulin supplements deficient endogenous production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Sensitivity.